| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9975123 | The Journal of Heart and Lung Transplantation | 2005 | 6 Pages |
Abstract
The effects of PGE1 and NO on pulmonary hypertension are comparable, with PGE1 having more systemic hypotensive effects. Due to variability of patient responses, we recommend multiple rather than single-agent pharmacologic testing for the reversibility of pulmonary hypertension.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Branislav MD, Bojan MD, PhD, Cynthia D. RN, Mihai MD, Timothy J. BS, Rajko MD, Tehreen MD, Edward K. MD, O.H. MD,